| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(87)80108-7 |
| P698 | PubMed publication ID | 3309233 |
| P2093 | author name string | Davidson GP | |
| Robb TA | |||
| Thompson GN | |||
| P2860 | cites work | Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis | Q34494540 |
| Conjugated bile acids in serum and secretions in response to cholecystokinin/secretin stimulation in children with cystic fibrosis | Q34527545 | ||
| Ileal resection: effect of cimetidine and taurine on intrajejunal bile acid precipitation and lipid solubilisation | Q34528403 | ||
| Revised standards for triceps and subscapular skinfolds in British children | Q34984949 | ||
| Intestinal bile salts in cystic fibrosis: studies in the patient and experimental animal | Q34986860 | ||
| Determination of Body Composition of Children from Skinfold Measurements | Q35148272 | ||
| Evaluation of growth rate in height over periods of less than one year | Q35148893 | ||
| Biochemistry and physiology of taurine and taurine derivatives | Q39889969 | ||
| Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes | Q42042094 | ||
| The two-period cross-over clinical trial | Q43247030 | ||
| A new prognostic score and clinical evaluation system for cystic fibrosis | Q43524203 | ||
| Role of taurine in feeding the low-birth-weight infant | Q47238638 | ||
| Effect of taurine supplements on fat absorption in cystic fibrosis. | Q51637965 | ||
| Effects of Taurine on Seizures and Growth Hormone Release in Epileptic Patients | Q66970757 | ||
| Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients | Q69551137 | ||
| Somatomedin in cystic fibrosis | Q71089413 | ||
| Growth depression in taurine-depleted infant monkeys | Q71334174 | ||
| Comparative effects of antacids, enteric coating, and bile salts on the efficacy of oral pancreatic enzyme therapy in cystic fibrosis | Q71899147 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cystic fibrosis | Q178194 |
| P304 | page(s) | 501-506 | |
| P577 | publication date | 1987-10-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Taurine supplementation, fat absorption, and growth in cystic fibrosis | |
| P478 | volume | 111 |
| Q46520394 | Bile acid conjugation and hepatic taurine concentration in rats fed on pectin |
| Q41226105 | Current knowledge on fatty acids in cystic fibrosis |
| Q37977706 | Cystic fibrosis, pathophysiological and clinical aspects |
| Q35627846 | Effect of taurine supplementation on fat and energy absorption in cystic fibrosis |
| Q44342031 | Failure of taurine to improve fat absorption in cystic fibrosis |
| Q35831797 | Growth failure in gastrointestinal diseases |
| Q90752800 | Interventions for preventing and managing advanced liver disease in cystic fibrosis |
| Q38604015 | Interventions for preventing and managing advanced liver disease in cystic fibrosis. |
| Q34759622 | Risk assessment for the amino acids taurine, L-glutamine and L-arginine |
| Q40443636 | Taurine in Pediatric Nutrition |
| Q74057449 | The role of vitamins in cystic fibrosis |
| Q35627841 | Thymopentin treatment in severe atopic dermatitis--clinical and immunological evaluations |
Search more.